Dolby Laboratories
$ 64.64
0.94%
17 Apr - close price
- Market Cap 6,175,694,000 USD
- Current Price $ 64.64
- High / Low $ 65.50 / 64.51
- Stock P/E 26.17
- Book Value 27.15
- EPS 2.47
- Next Earning Report 2026-04-30
- Dividend Per Share $1.38
- Dividend Yield 2.15 %
- Next Dividend Date -
- ROA 0.05 %
- ROE 0.09 %
- 52 Week High 77.08
- 52 Week Low 57.62
About
Dolby Laboratories, Inc. creates imaging and audio technologies that transform entertainment and communications in the theater, home, work, and mobile devices. The company is headquartered in San Francisco, California.
Analyst Target Price
$81.00
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-01-29 | 2025-11-18 | 2025-07-31 | 2025-04-30 | 2025-01-30 | 2024-11-19 | 2024-08-07 | 2024-05-02 | 2024-02-01 | 2023-11-16 | 2023-08-03 | 2023-05-04 |
| Reported EPS | 1.06 | 0.99 | 0.78 | 1.34 | 1.14 | 0.81 | 0.71 | 1.27 | 1.01 | 0.65 | 0.55 | 1.26 |
| Estimated EPS | 0.88 | 0.7 | 0.71 | 1.2667 | 0.9767 | 0.7 | 0.59 | 1.19 | 0.86 | 0.53 | 0.55 | 0.98 |
| Surprise | 0.18 | 0.29 | 0.07 | 0.0733 | 0.1633 | 0.11 | 0.12 | 0.08 | 0.15 | 0.12 | 0 | 0.28 |
| Surprise Percentage | 20.4545% | 41.4286% | 9.8592% | 5.7867% | 16.7196% | 15.7143% | 20.339% | 6.7227% | 17.4419% | 22.6415% | 0% | 28.5714% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-04-30 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | 1.03 |
| Currency | USD |
Previous Dividend Records
| Feb 2026 | Dec 2025 | Aug 2025 | May 2025 | Feb 2025 | Dec 2024 | Aug 2024 | May 2024 | Feb 2024 | Dec 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-02-18 | 2025-12-10 | 2025-08-20 | 2025-05-21 | 2025-02-19 | 2024-12-10 | 2024-08-27 | 2024-05-22 | 2024-02-22 | 2023-12-05 |
| Amount | $0.36 | $0.36 | $0.33 | $0.33 | $0.33 | $0.33 | $0.3 | $0.3 | $0.3 | $0.3 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: DLB
2026-04-16 10:10:43
Dolby Laboratories announced at CinemaCon that EVO Entertainment will equip its EVX Premium Large Format auditoriums with Dolby Vision and Dolby Atmos. This integration will cover 17 screens across eight cinema entertainment centers in Texas, New Mexico, and Florida, with the new flagship EVO Entertainment venue in Clearwater being the first multiplex fully powered by Dolby Vision and Dolby Atmos, featuring the world's largest cinema screen. This partnership aims to enhance the cinematic experience, drawing audiences with superior picture and sound quality.
2026-04-09 07:10:27
Dolby Laboratories, Inc. (NYSE: DLB) will release its Q2 fiscal year 2026 financial results after market close on Thursday, April 30, 2026. Management will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) on the same day to discuss the results. Interested parties can register online for dial-in information or access the live audio webcast at http://investor.dolby.com.
2026-04-04 11:09:07
Emily Rollins, a director at Dolby Laboratories, Inc. (NASDAQ:DLB), sold 1,000 shares of Class A Common Stock for $60,080 on April 1, 2026. Following the sale, Rollins directly owns 12,541 shares. This transaction occurred shortly after Dolby Laboratories reported strong first-quarter 2026 financial results, with EPS and revenue exceeding expectations.
2026-04-04 00:10:27
Emily Rollins, a director at Dolby Laboratories, Inc., sold 1,000 shares of Class A Common Stock for $60.08 per share, totaling $60,080. Following the transaction, Rollins directly owns 12,541 shares. This sale comes after Dolby Laboratories reported strong Q1 2026 financial results, with EPS and revenue exceeding expectations.
2026-04-03 21:35:37
Emily Rollins, a director at Dolby Laboratories (NASDAQ:DLB), sold 1,000 shares of Class A Common Stock for a total of $60,080 on April 1, 2026. Following this transaction, Rollins directly owns 12,541 shares. This sale comes after Dolby Laboratories reported strong financial results for Q1 2026, with EPS and revenue surpassing expectations.
2026-04-03 21:11:37
Emily Rollins, a director at Dolby Laboratories (DLB), reported an open-market sale of 1,000 shares of Class A common stock at $60.08 per share on April 1, 2026. Following this transaction, she directly holds 12,541 shares, which include 3,908 shares underlying restricted stock units that are subject to forfeiture until they vest. The transaction, filed as a Form 4, indicates a net sale of 1,000 shares valued at $60,080.
